RP Bio Inc. (KOSDAQ:314140)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,600.00
-140.00 (-2.08%)
At close: Mar 9, 2026
27.66%
Market Cap 57.20B
Revenue (ttm) 134.21B
Net Income (ttm) 4.89B
Shares Out 8.67M
EPS (ttm) 564.30
PE Ratio 11.70
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 33,914
Average Volume 27,796
Open 6,600.00
Previous Close 6,740.00
Day's Range 6,290.00 - 6,600.00
52-Week Range 4,765.00 - 9,130.00
Beta 0.55
RSI 47.55
Earnings Date n/a

About RP Bio

RP Bio Inc., a bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally. It offers animal, vegetable, antihistamine, and chewable soft capsules; hard capsules; and jelly and powder sticks; Urusa, flagship soft capsule; omega-3 and lutein products, and granule, effervescent granule, and stick type capsule powders. The company also provides cold and liver medicines; vitamins; blood circulation improvers; and pain relievers. The company was founded in 1983 and is headquartered in... [Read more]

Industry Pharmaceutical Preparations
Founded 1983
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 314140
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.